Doroteya Raykova
Doroteya Raykova
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,✉,#,
Despoina Kermpatsou
Despoina Kermpatsou
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,#,
Tony Malmqvist
Tony Malmqvist
2Atlas Antibodies AB, Bromma, Sweden
2,
Philip J Harrison
Philip J Harrison
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Marie Rubin Sander
Marie Rubin Sander
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Christiane Stiller
Christiane Stiller
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Johan Heldin
Johan Heldin
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Mattias Leino
Mattias Leino
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Sara Ricardo
Sara Ricardo
3Faculty of Medicine, University of Porto, Porto, Portugal
4Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
5Department of Sciences, University Institute of Health Sciences (IUCS), CESPU, Gandra, Portugal
3,4,5,
Anna Klemm
Anna Klemm
6Vi2, Department of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden
6,
Leonor David
Leonor David
3Faculty of Medicine, University of Porto, Porto, Portugal
4Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
3,4,
Ola Spjuth
Ola Spjuth
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Kalyani Vemuri
Kalyani Vemuri
7Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden
7,
Anna Dimberg
Anna Dimberg
7Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden
7,
Anders Sundqvist
Anders Sundqvist
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Maria Norlin
Maria Norlin
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Axel Klaesson
Axel Klaesson
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,
Caroline Kampf
Caroline Kampf
2Atlas Antibodies AB, Bromma, Sweden
2,
Ola Söderberg
Ola Söderberg
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
1,✉
1Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden
2Atlas Antibodies AB, Bromma, Sweden
3Faculty of Medicine, University of Porto, Porto, Portugal
4Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
5Department of Sciences, University Institute of Health Sciences (IUCS), CESPU, Gandra, Portugal
6Vi2, Department of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden
7Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden
Subject terms: Proteomic analysis, Fluorescence imaging, Protein-protein interaction networks, Protein-protein interaction networks
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
